Correlation Between Verve Therapeutics and Novo Nordisk
Can any of the company-specific risk be diversified away by investing in both Verve Therapeutics and Novo Nordisk at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Verve Therapeutics and Novo Nordisk into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Verve Therapeutics and Novo Nordisk AS, you can compare the effects of market volatilities on Verve Therapeutics and Novo Nordisk and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Verve Therapeutics with a short position of Novo Nordisk. Check out your portfolio center. Please also check ongoing floating volatility patterns of Verve Therapeutics and Novo Nordisk.
Diversification Opportunities for Verve Therapeutics and Novo Nordisk
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Verve and Novo is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Verve Therapeutics and Novo Nordisk AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novo Nordisk AS and Verve Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Verve Therapeutics are associated (or correlated) with Novo Nordisk. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novo Nordisk AS has no effect on the direction of Verve Therapeutics i.e., Verve Therapeutics and Novo Nordisk go up and down completely randomly.
Pair Corralation between Verve Therapeutics and Novo Nordisk
Given the investment horizon of 90 days Verve Therapeutics is expected to under-perform the Novo Nordisk. In addition to that, Verve Therapeutics is 2.82 times more volatile than Novo Nordisk AS. It trades about -0.02 of its total potential returns per unit of risk. Novo Nordisk AS is currently generating about 0.06 per unit of volatility. If you would invest 6,339 in Novo Nordisk AS on August 31, 2024 and sell it today you would earn a total of 4,274 from holding Novo Nordisk AS or generate 67.42% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Verve Therapeutics vs. Novo Nordisk AS
Performance |
| Timeline |
| Verve Therapeutics |
| Novo Nordisk AS |
Verve Therapeutics and Novo Nordisk Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Verve Therapeutics and Novo Nordisk
The main advantage of trading using opposite Verve Therapeutics and Novo Nordisk positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Verve Therapeutics position performs unexpectedly, Novo Nordisk can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novo Nordisk will offset losses from the drop in Novo Nordisk's long position.| Verve Therapeutics vs. Adaptive Biotechnologies Corp | Verve Therapeutics vs. Beam Therapeutics | Verve Therapeutics vs. Caribou Biosciences | Verve Therapeutics vs. Sana Biotechnology |
| Novo Nordisk vs. Regeneron Pharmaceuticals | Novo Nordisk vs. Crispr Therapeutics AG | Novo Nordisk vs. Sarepta Therapeutics | Novo Nordisk vs. Intellia Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |